Corresponding Author: Eli S. Rosenberg, PhD, Department of Epidemiology and Biostatistics, University at Albany School of Public Health, One University Pl, Room 123, Albany, NY 12203 (erosenberg2@albany.edu).
Published Online: May 11, 2020. doi:10.1001/jama.2020.8630
Author Contributions: Dr Rosenberg had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Rosenberg, Dufort, Udo, Wilberschied, Kumar, Kirkwood, DeHovitz, Blog, Hutton, Holtgrave, Zucker.
Acquisition, analysis, or interpretation of data: Rosenberg, Dufort, Udo, Wilberschied, Kumar, Tesoriero, Weinberg, Kirkwood, Muse, DeHovitz, Blog, Holtgrave.
Drafting of the manuscript: Rosenberg, Dufort, Udo, Wilberschied, Kumar, Blog, Holtgrave.
Critical revision of the manuscript for important intellectual content: Rosenberg, Dufort, Udo, Wilberschied, Kumar, Tesoriero, Weinberg, Kirkwood, Muse, DeHovitz, Hutton, Holtgrave, Zucker.
Statistical analysis: Rosenberg, Udo, Wilberschied, Kumar, Holtgrave.
Obtained funding: Dufort, Tesoriero.
Administrative, technical, or material support: All authors.
Supervision: Rosenberg, Dufort, Weinberg, Blog, Hutton, Holtgrave.
Conflict of Interest Disclosures: Dr Dufort reported that her spouse has a Gilead Foundation-Focus HIV/HCV testing research grant. No other disclosures were reported.
Additional Contributions: The authors wish to acknowledge the following contributors to this work, who did not receive any specific compensation for their contributions. From IPRO: Wendy Ferguson, DipED, Allison Xiong, PhD, Matthew Roberts, DrPH, Kathleen Terry, PhD, Lois Piper, MBA, as well as the nursing and analytical team. From University at Albany: Janine Jurkowski, PhD, and Kerianne Engesser, BS. From New York State Department of Health Emerging Infections Program: Jemma Rowlands, MPH, Grant Barney, MPH, Nancy Spina, MPH, Rachel Wester, MPH. From New York State Department of Health Office of Quality and Patient Safety: Meng Wu, PhD, and Deirdre Depew, ME. From New York State Department of Health AIDS Institute: Michelle Cummings, MS. From New York State Department of Health Center for Community Health: Thomas Justin II, BSc. From New York State Department of Health Office of Primary Care and Health Systems Management: Daniel McNamara, BSPharm, and Kimberly Leonard, BSPharm. From Albany College of Pharmacy and Health Sciences: Darren Grabe, PharmD. From New York University Langone Medical Center: Mark Mulligan, MD, Robert Ulrich, MD, and Ellie Carmody, MD. New York State Department of Health and University at Albany employees worked on this study as part of their duties. IPRO employees work under a standing contract with the State of New York to conduct medical record extraction duties and other tasks, and their medical record extraction work was done as part of that standing contract. No grants were awarded for this study to the University at Albany. No funding was provided to New York University Langone Medical Center for the consultation of Drs Mulligan, Ulrich, and Carmody on this study. No funding was provided to Albany College of Pharmacy and Health Sciences for the consultation of Dr Grabe.
3.Rosenberg
ES , Dufort
EM , Blog
DS ,
et al. COVID-19 testing, epidemic features, hospital outcomes, and household prevalence, New York State—March 2020.
Clin Infect Dis. Published online May 8, 2020. doi:
10.1093/cid/ciaa549Google Scholar 6.Yao
X , Ye
F , Zhang
M ,
et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Clin Infect Dis. 2020;ciaa237. doi:
10.1093/cid/ciaa237
PubMedGoogle Scholar 9.Chen
Z , Hu
J , Zhang
Z ,
et al Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial.
medRxiv. Preprint posted April 10, 2020. doi:
10.1101/2020.03.22.20040758 10.McGhie
TK , Harvey
P , Su
J , Anderson
N , Tomlinson
G , Touma
Z . Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus.
Clin Exp Rheumatol. 2018;36(4):545-551.
PubMedGoogle Scholar 11.Hung
YM , Wang
YH , Lin
L , Wang
PYP , Chiou
JY , Wei
JC . Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: A nationwide population-based cohort study.
Int J Clin Pract. 2018;72(5):e13095. doi:
10.1111/ijcp.13095
PubMedGoogle Scholar 12.Chorin
E , Dai
M , Shulman
E ,
et al. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.
Nat Med. Published online April 24, 2020. doi:
10.1038/s41591-020-0888-2Google Scholar 13.Borba
MGS , Val
FFA , Sampaio
VS ,
et al Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial.
JAMA Netw Open. 2020;3(4):e208857. doi:
10.1001/jamanetworkopen.2020.8857
Google Scholar 14.FDA. Fact sheet for health care providers: emergency use authorization (EUA) of hydroxychloroquine sulfate supplied from the strategic national stockpile for treatment of COVID-19 in certain hospitalized patients. Posted April 27, 2020. Accessed May 7, 2020.
https://www.fda.gov/media/136537/download 15.Garg
S , Kim
L , Whitaker
M ,
et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 States, March 1-30, 2020.
MMWR Morb Mortal Wkly Rep. 2020;69(15):458-464. doi:
10.15585/mmwr.mm6915e3
PubMedGoogle ScholarCrossref 16.CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12-March 28, 2020.
MMWR Morb Mortal Wkly Rep. 2020;69(13):382-386. doi:
10.15585/mmwr.mm6913e2
PubMedGoogle ScholarCrossref 17.Magagnoli
J , Narendran
S , Pereira
F ,
et al Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19.
medRxiv. Preprint posted April 23, 2020. doi:
10.1101/2020.04.16.20065920 19.Petrilli
CM , Jones
SA , Yang
J ,
et al Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City.
medRxiv. Preprint posted April 11, 2020. doi:
10.1101/2020.04.08.20057794 20.Davis
CE , Hyde
JE , Bangdiwala
SI , Nelson
JJ . An example of dependencies among variables in a conditional logistic regression. In: Modern Statistical Methods in Chronic Disease Epidemiology. John Wiley & Sons; 1986:140-147.
23.Mahevas
M , Tran V-T, Roumier M, et al. No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial.
medRxiv. Preprint posted April 14, 2020. doi:
10.1101/2020.04.10.20060699 27.Richardson
S , Hirsch
JS , Narasimhan
M ,
et al; and the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area.
JAMA. Published online April 22, 2020. doi:
10.1001/jama.2020.6775
PubMedGoogle Scholar 32.FDA Drug Safety Communication. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. Posted April 24, 2020. Accessed May 8, 2020.
https://www.fda.gov/media/137250/download